Up to May, 2008, 166 phosphorylated sites have been identified of 95 signal pathway proteins in breast cancer tissues, by using EnoGene's antibodies
EnoGene aims to be a leading manufacturer of quality antibody products for the biotechnology, animal and human pharmaceutical industries.
EnoGene says it believes tissue will tell us more.
EnoGene describes itself as one of the most advanced established biotechnology companies with core technologies in high efficiency of antibody production and large scale antibody purification.
EnoGene currently manufactures and markets antibody products for use in life science research, biopharmaceutical manufacturing and diagnostics.
